Tolterodine
Tolterodine | CAS NO: 124937-52-6 Tolterodine is a medication primarily used to treat overactive bladder (OAB). It is an antimuscarinic agent that helps manage symptoms associated with this condition. Treatment of Overactive Bladder (OAB): Tolterodine helps to reduce symptoms of OAB, such as frequent urination, urgency, and urge incontinence. It works by relaxing the bladder muscle and decreasing involuntary contractions, which can help increase bladder capacity and reduce the need for frequent bathroom visits. Management of Urge Incontinence: This condition involves involuntary leakage of urine that is preceded by a sudden, strong urge to urinate. Tolterodine can help manage this by reducing the frequency and urgency of these episodes. Tolterodine is available in both immediate-release and extended-release formulations. The choice of formulation and dosage depends on individual patient needs and responses.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Tolterodine impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities Tolterodine is primarily used for managing conditions related to overactive bladder (OAB). Frequent Urination: The need to urinate more often than usual. Urgency: A strong, sudden urge to urinate that can be difficult to control. Urgency Incontinence: Involuntary leakage of urine that follows an urgent need to urinate.we the Synchemia are ensuring the purity and quality of its impurities which is crucial for pharmaceutical API manufacturing companies for regulatory compliance. Buy Reliable and High-Purity Tolterodine Impurities, Delivered by Synchemia Research Chemicals.
Pharmaceutical Reference Standards
| CAT No | SRC-T20347 |
| CAS No | 1203453-90-0 |
| Mol.F. | C16H19NO |
| Mol.Wt. | 241.33 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-T20348 |
| CAS No | 173948-30-6 |
| Mol.F. | C15H23N |
| Mol.Wt. | 217.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20349 |
| CAS No | 156755-37-2 |
| Mol.F. | C29H37NO2 |
| Mol.Wt. | 431.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20350 |
| CAS No | 894773-86-5 |
| Mol.F. | C18H22O6S2 |
| Mol.Wt. | 398.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20351 |
| CAS No | 124937-52-6 |
| Mol.F. | C22H31NO : C4H6O6 |
| Mol.Wt. | 325.5 : 150.1g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20352 |
| CAS No | 207679-81-0 |
| Mol.F. | C22H31NO2 |
| Mol.Wt. | 341.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20352 |
| CAS No | 200801-70-3 |
| Mol.F. | C22H31NO2 |
| Mol.Wt. | 341.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20353 |
| CAS No | 1390644-37-7 |
| Mol.F. | C26H35NO3 |
| Mol.Wt. | 409.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20354 |
| CAS No | 1554029-92-3 |
| Mol.F. | C22H31NO2 : C2F3O2 |
| Mol.Wt. | 342.5 : 113.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20355 |
| CAS No | 848768-06-9 |
| Mol.F. | C29H37NO |
| Mol.Wt. | 415.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20356 |
| CAS No | 2514856-06-3 |
| Mol.F. | C18H20O3 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20357 |
| CAS No | 2732261-51-5 |
| Mol.F. | C37H54N2O |
| Mol.Wt. | 542.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20358 |
| CAS No | NA |
| Mol.F. | C30H48N2O |
| Mol.Wt. | 452.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20359 |
| CAS No | 2724801-37-8 |
| Mol.F. | C37H54N2O |
| Mol.Wt. | 542.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20360 |
| CAS No | 906532-18-1 |
| Mol.F. | C22H31NO |
| Mol.Wt. | 325.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20361 |
| CAS No | 2725236-41-7 |
| Mol.F. | C16H19NO |
| Mol.Wt. | 241.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.